These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
250 related items for PubMed ID: 7505004
21. An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia. Anargyrou K, Paterakis G, Boutsis D, Politou M, Papadhimitriou SI, Siakandaris M, Vassiliadis J, Androulakis A, Meletis J, Rombos J, Tassiopoulou A, Vaiopoulos G. Eur J Haematol; 2003 Oct; 71(4):294-8. PubMed ID: 12950240 [Abstract] [Full Text] [Related]
22. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells. Ohkawa T, Seki S, Dobashi H, Koike Y, Habu Y, Ami K, Hiraide H, Sekine I. Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057 [Abstract] [Full Text] [Related]
23. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10. Goodier MR, Londei M. J Immunol; 2000 Jul 01; 165(1):139-47. PubMed ID: 10861046 [Abstract] [Full Text] [Related]
24. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells. Boissel L, Tuncer HH, Betancur M, Wolfberg A, Klingemann H. Biol Blood Marrow Transplant; 2008 Sep 01; 14(9):1031-1038. PubMed ID: 18721766 [Abstract] [Full Text] [Related]
26. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells. Condiotti R, Nagler A. Exp Hematol; 1998 Jul 01; 26(7):571-9. PubMed ID: 9657131 [Abstract] [Full Text] [Related]
27. The IL-12 signature: NK cell terminal CD56+high stage and effector functions. Loza MJ, Perussia B. J Immunol; 2004 Jan 01; 172(1):88-96. PubMed ID: 14688313 [Abstract] [Full Text] [Related]
29. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins. Phillips JH, Hori T, Nagler A, Bhat N, Spits H, Lanier LL. J Exp Med; 1992 Apr 01; 175(4):1055-66. PubMed ID: 1372642 [Abstract] [Full Text] [Related]
30. A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing. Hernández-Caselles T, Martínez-Esparza M, Pérez-Oliva AB, Quintanilla-Cecconi AM, García-Alonso A, Alvarez-López DM, García-Peñarrubia P. J Leukoc Biol; 2006 Jan 01; 79(1):46-58. PubMed ID: 16380601 [Abstract] [Full Text] [Related]
31. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Mrózek E, Anderson P, Caligiuri MA. Blood; 1996 Apr 01; 87(7):2632-40. PubMed ID: 8639878 [Abstract] [Full Text] [Related]
32. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement. Nagata T, Higashigawa M, Nagai M, Zhang XL, Azuma E, Komada Y, Sakurai M. Leuk Res; 1996 Apr 01; 20(11-12):983-5. PubMed ID: 9009257 [Abstract] [Full Text] [Related]
33. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies. Yamada O, Ichikawa M, Okamoto T, Park C, Motoji T, Mizoguchi H, Shibuya A. Br J Haematol; 2001 Apr 01; 113(1):153-60. PubMed ID: 11328295 [Abstract] [Full Text] [Related]
34. Chronic myelomonocytic leukemia derived from a possible common progenitor of monocytes and natural killer cells. Kojima H, Bai A, Mukai HY, Hori M, Komeno T, Hasegawa Y, Ninomiya H, Mori N, Nagasawa T. Leuk Lymphoma; 2000 May 01; 37(5-6):617-21. PubMed ID: 11042523 [Abstract] [Full Text] [Related]
35. Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells. Vivier E, Sorrell JM, Ackerly M, Robertson MJ, Rasmussen RA, Levine H, Anderson P. J Exp Med; 1993 Dec 01; 178(6):2023-33. PubMed ID: 7504054 [Abstract] [Full Text] [Related]
37. Expansion of CD56+ NK T and gamma delta T cells from cord blood of human neonates. Musha N, Yoshida Y, Sugahara S, Yamagiwa S, Koya T, Watanabe H, Hatakeyama K, Abo T. Clin Exp Immunol; 1998 Aug 01; 113(2):220-8. PubMed ID: 9717971 [Abstract] [Full Text] [Related]
38. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. Moretta A, Bottino C, Pende D, Tripodi G, Tambussi G, Viale O, Orengo A, Barbaresi M, Merli A, Ciccone E. J Exp Med; 1990 Dec 01; 172(6):1589-98. PubMed ID: 2147946 [Abstract] [Full Text] [Related]
39. Immunophenotype of peripheral T lymphocytes, NK cells and expression of CD69 activation marker in patients with recurrent spontaneous abortions, during the mid-luteal phase. Prado-Drayer A, Teppa J, Sánchez P, Camejo MI. Am J Reprod Immunol; 2008 Jul 01; 60(1):66-74. PubMed ID: 18593439 [Abstract] [Full Text] [Related]
40. Variation of human natural killer cell phenotypes with age: identification of a unique KLRG1-negative subset. Hayhoe RP, Henson SM, Akbar AN, Palmer DB. Hum Immunol; 2010 Jul 01; 71(7):676-81. PubMed ID: 20394788 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]